Jade Biosciences, Inc. (JBIO)
20.07
-1.33
(-6.21%)
USD |
NASDAQ |
Sep 03, 14:14
Jade Biosciences Debt to Equity Ratio : 0.0014 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0014 |
| March 31, 2026 | 0.0023 |
| December 31, 2025 | 0.0022 |
| September 30, 2025 | 0.0042 |
| June 30, 2025 | 0.0039 |
| March 31, 2025 | 0.0042 |
| December 31, 2024 | 0.0055 |
| September 30, 2024 | 0.0067 |
| June 30, 2024 | 0.0072 |
| March 31, 2024 | 0.0085 |
| December 31, 2023 | 0.0062 |
| September 30, 2023 | 0.0064 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.006 |
| March 31, 2023 | 0.0085 |
| December 31, 2022 | 0.0086 |
| September 30, 2022 | 0.0085 |
| June 30, 2022 | 0.0024 |
| March 31, 2022 | 0.0013 |
| December 31, 2021 | 0.0033 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics, Inc. | 0.0122 |
| Cue Biopharma, Inc. | 3.813 |
| Praxis Precision Medicines, Inc. | 0.0008 |
| Opus Genetics, Inc. | -2.788 |
| Faeth Therapeutics, Inc. | 0.0033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 472.11M |
| Total Liabilities (Quarterly) | 32.20M |
| Shareholders Equity (Quarterly) | 439.92M |
| Current Ratio | 14.93 |
| Net Debt Paydown Yield | 0.00% |